Anixa Biosciences is a biotech company that focuses on developing therapies and vaccines to tackle the unmet needs in cancer and infectious diseases. They have multiple programs in pipeline including CAR-T cell technology for ovarian cancer, drugs to treat COVID-19 and vaccines against triple-negative breast cancer and ovarian cancer. They also have a collaboration agreement with MolGenie GmbH for developing anti-viral drug candidates against COVID-19.